Re: IP ownership - industry-sponsored clinical trials Smith, Debbie L 24 Sep 2009 14:19 EST
It's been our experience that it's very difficult to negotiate IP rights when the sponsor both owns the product and wrote the protocol. We do, however, try not to let the sponsor define their IP so broadly that we'd have to cut off the PI's head in order to comply! . . . or reach-through language that might affect research we do with the product after it's approved down the road. If it's our protocol, we expect to own IP resulting from it but can offer a license to the sponsor. ds Deborah (Debbie) L. Smith, Ed.D. Assistant Vice Chancellor for Research UT Health Science Center Office of Research Administration 910 Madison, Suite 823 Memphis, TN 38163 901 448-4823 901 448-7600 fax xxxxxx@utmem.edu P Please consider the environment before printing. Reduce - Reuse - Recycle θ -----Original Message----- From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of Wu, Linda (LLU) Sent: Thursday, September 24, 2009 11:11 AM To: xxxxxx@hrinet.org Subject: Re: [RESADM-L] IP ownership - industry-sponsored clinical trials Only when there is new discovery / unanticipated that university could negotiate partial /shared IP. Would like to hear what others' experience. linda -----Original Message----- From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of Zoya Hamilton Sent: Thursday, September 24, 2009 8:49 AM To: xxxxxx@hrinet.org Subject: [RESADM-L] IP ownership - industry-sponsored clinical trials Dear Colleagues, Do you accept the ownership of IP by the sponsoring company on clinical trials? In other words, are you always successful in negotiating the university ownership of IP? Thanks for your input, Zoya -- Zoya Hamilton, CRA Sr. Associate Director, Research Administration Office of the Vice Provost Tufts University Tel (617) 636-6709 Fax (617) 636-2917 http://researchadmin.tufts.edu/ ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================